Duration of Immunotherapy for NSCLC – OncLive
|
Duration of Immunotherapy for NSCLC
OncLive So, it seems to me that probably the most important study to be done is not this type of study, but it’s a study that is looking about the opportunity to continue immunotherapy for those patients who are in CR or PR. And probably we need to do a … |
Parkinson’s News Today |
Voyager’s AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinson’s
Parkinson’s News Today The company presented ongoing Phase 1b trial (NCT01973543) results at the Oct. 17-20 Congress of the European Society of Gene and Cell Therapy (ESGCT) in Berlin, in a talk titled “Intraputaminal AADC gene therapy for advanced Parkinson’s disease: … |
Genetic Engineering & Biotechnology News |
New Version of CRISPR, Developed by Feng Zhang–Led Team, Can Target and Edit RNA
Genetic Engineering & Biotechnology News A research team led by Feng Zhang, Ph.D., has developed a new version of the gene-editing tool CRISPR (clustered regularly interspaced short palindromic repeats) that offers several advantages over its familiar DNA-editing counterpart through its … Gene-editing tool CRISPR can now manipulate more types of genetic materialThe Verge CRISPR 2.0 Is Here, and It’s Way More PreciseMIT Technology Review New CRISPR tool alters RNA for wider gene editing applicationsEngadget Science Magazine –WIRED –STAT –Science all 69 news articles » |
PLoS Blogs (blog) |
What Should Gene Therapy Cost?
PLoS Blogs (blog) By the time that the FDA’s advisory committee gave a near-instantaneous and unanimous thumbs-up for gene therapy to treat a form of hereditary blindness on October 12, tears were freely flowing. Fittingly, it was World Sight Day. The new drug, Luxturna … |